org25435
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2000 (NCT01062867)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Gamma-amino-N-butyrate transaminaseACTIVATOR
ABAT activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 2-(n-bis(2-methoxyethyl)amino)butyric acid,2',6'-dimethoxyphenyl ester hydrobromide
- org25435
- org25435
- org25435
- org 25435
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01062867 | Phase 1 | Jan 1, 2000 | Organon, University of Plymouth, Veeda Clinical Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Organon | For profit | 1 | 0 | 1 | 2000 |
| University of Plymouth | Academic/Hospital | 1 | 1 | 1 | 2000 |
| Veeda Clinical Research | For profit | 1 | 0 | 1 | 2000 |
3 organizations
Page 1 / 1